FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023546954> ?p ?o ?g. }

• W2023546954 endingPage "202" @default.
• W2023546954 startingPage "199" @default.
• W2023546954 abstract "Chronic pulmonary infection is the major cause of morbidity and mortality in cystic fibrosis. High levels of DNA in the sputum make the sputum viscous and difficult to expectorate. Recombinant human deoxyribonuclease (rhDNase) in vitro has been shown to reduce the viscoelasticity of the sputum from CF patients. We have done a phase II double-blind randomised placebo-controlled trial in which patients received either 2·5 mg rhDNase twice daily or placebo for 10 days. All patients had forced vital capacity (FVC) above 40% predicted and were clinically stable. Patients were followed up for 42 days from the start of drug/placebo administration. All 71 randomised patients, aged 16-55, completed every aspect of the study and baseline characteristics were similar in the two groups. Baseline forced expiratory volume in one second (FEV1) was 46% of predicted for patients randomised to rhDNase, and 48% for those randomised to placebo; and baseline FVC was 76% of predicted for both groups. The mean percentage change in FEV1 from baseline was a 13 3% rise on rhDNase and a 0·2% fall on placebo (p<0·001). FVC rose 7 2% in the rhDNase group and 2·3% in the placebo group (not significant). There were no life-threatening adverse events and no anaphylactic reactions. There was no significant difference in side-effects between the groups. This study confirms that short-term administration of rhDNase in stable patients with cystic fibrosis is safe and improves lung function." @default.
• W2023546954 created "2016-06-24" @default.
• W2023546954 creator A5018950216 @default.
• W2023546954 creator A5035135989 @default.
• W2023546954 creator A5048859997 @default.
• W2023546954 creator A5054075618 @default.
• W2023546954 creator A5055108502 @default.
• W2023546954 creator A5063814256 @default.
• W2023546954 creator A5081740012 @default.
• W2023546954 creator A5086205526 @default.
• W2023546954 date "1993-07-01" @default.
• W2023546954 modified "2023-09-25" @default.
• W2023546954 title "Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis" @default.
• W2023546954 cites W1513861892 @default.
• W2023546954 cites W1522965808 @default.
• W2023546954 cites W1892403664 @default.
• W2023546954 cites W1997182007 @default.
• W2023546954 cites W2035561609 @default.
• W2023546954 cites W2045196836 @default.
• W2023546954 cites W2049355530 @default.
• W2023546954 cites W2092048896 @default.
• W2023546954 cites W2094395573 @default.
• W2023546954 cites W2117131869 @default.
• W2023546954 cites W2125920116 @default.
• W2023546954 cites W2153495209 @default.
• W2023546954 cites W2336714143 @default.
• W2023546954 cites W3023243658 @default.
• W2023546954 cites W4230981577 @default.
• W2023546954 cites W4232969935 @default.
• W2023546954 doi "https://doi.org/10.1016/0140-6736(93)92297-7" @default.
• W2023546954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8100928" @default.
• W2023546954 hasPublicationYear "1993" @default.
• W2023546954 type Work @default.
• W2023546954 sameAs 2023546954 @default.
• W2023546954 citedByCount "184" @default.
• W2023546954 countsByYear W20235469542012 @default.
• W2023546954 countsByYear W20235469542013 @default.
• W2023546954 countsByYear W20235469542014 @default.
• W2023546954 countsByYear W20235469542016 @default.
• W2023546954 countsByYear W20235469542017 @default.
• W2023546954 countsByYear W20235469542018 @default.
• W2023546954 countsByYear W20235469542021 @default.
• W2023546954 countsByYear W20235469542022 @default.
• W2023546954 countsByYear W20235469542023 @default.
• W2023546954 crossrefType "journal-article" @default.
• W2023546954 hasAuthorship W2023546954A5018950216 @default.
• W2023546954 hasAuthorship W2023546954A5035135989 @default.
• W2023546954 hasAuthorship W2023546954A5048859997 @default.
• W2023546954 hasAuthorship W2023546954A5054075618 @default.
• W2023546954 hasAuthorship W2023546954A5055108502 @default.
• W2023546954 hasAuthorship W2023546954A5063814256 @default.
• W2023546954 hasAuthorship W2023546954A5081740012 @default.
• W2023546954 hasAuthorship W2023546954A5086205526 @default.
• W2023546954 hasConcept C126322002 @default.
• W2023546954 hasConcept C141071460 @default.
• W2023546954 hasConcept C142724271 @default.
• W2023546954 hasConcept C165637977 @default.
• W2023546954 hasConcept C197934379 @default.
• W2023546954 hasConcept C204787440 @default.
• W2023546954 hasConcept C27081682 @default.
• W2023546954 hasConcept C2776301714 @default.
• W2023546954 hasConcept C2776938444 @default.
• W2023546954 hasConcept C2777714996 @default.
• W2023546954 hasConcept C2781069245 @default.
• W2023546954 hasConcept C3018587741 @default.
• W2023546954 hasConcept C42219234 @default.
• W2023546954 hasConcept C55520419 @default.
• W2023546954 hasConcept C71924100 @default.
• W2023546954 hasConcept C75603125 @default.
• W2023546954 hasConcept C90924648 @default.
• W2023546954 hasConceptScore W2023546954C126322002 @default.
• W2023546954 hasConceptScore W2023546954C141071460 @default.
• W2023546954 hasConceptScore W2023546954C142724271 @default.
• W2023546954 hasConceptScore W2023546954C165637977 @default.
• W2023546954 hasConceptScore W2023546954C197934379 @default.
• W2023546954 hasConceptScore W2023546954C204787440 @default.
• W2023546954 hasConceptScore W2023546954C27081682 @default.
• W2023546954 hasConceptScore W2023546954C2776301714 @default.
• W2023546954 hasConceptScore W2023546954C2776938444 @default.
• W2023546954 hasConceptScore W2023546954C2777714996 @default.
• W2023546954 hasConceptScore W2023546954C2781069245 @default.
• W2023546954 hasConceptScore W2023546954C3018587741 @default.
• W2023546954 hasConceptScore W2023546954C42219234 @default.
• W2023546954 hasConceptScore W2023546954C55520419 @default.
• W2023546954 hasConceptScore W2023546954C71924100 @default.
• W2023546954 hasConceptScore W2023546954C75603125 @default.
• W2023546954 hasConceptScore W2023546954C90924648 @default.
• W2023546954 hasIssue "8865" @default.
• W2023546954 hasLocation W20235469541 @default.
• W2023546954 hasLocation W20235469542 @default.
• W2023546954 hasOpenAccess W2023546954 @default.
• W2023546954 hasPrimaryLocation W20235469541 @default.
• W2023546954 hasRelatedWork W1996506769 @default.
• W2023546954 hasRelatedWork W2005806130 @default.
• W2023546954 hasRelatedWork W2023546954 @default.
• W2023546954 hasRelatedWork W2090298679 @default.
• W2023546954 hasRelatedWork W2110807723 @default.
• W2023546954 hasRelatedWork W2143750162 @default.

• next